YDU-33651-81446
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 450 / OH
- Registered
- 2021-09-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-28
Dose 1 — Pfizer-BioNTech
-
2021-09-18
Dose 2 — Pfizer-BioNTech
-
2021-09-19
Registered in v-safe
-
2021-09-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-09-21
- 2021-09-22
- 2021-09-23
- 2021-09-24
- 2021-09-25
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-12-18
-
2022-03-19
Survey response — 6 months, dose 2MedDRA: Joint swelling — Feeling: GoodFree text: ankle swellingMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-28 | Pfizer-BioNTech | No |
| 2 | 2021-09-18 | Pfizer-BioNTech | No |
Free text
Release 11 — 6 months, dose 2
Symptoms: ankle swelling
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Joint swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release